Picture of Jubilant Pharmova logo

JUBLPHARMA — Jubilant Pharmova News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

India's Jubilant Pharmova falls after USFDA issues observations on Washington unit

** Shares of Jubilant Pharmova  JUBA.NS  fall as much as
3.3% to 732.35 rupees; last down 1.7% 
    ** The pharmaceuticals company said on Friday that the U.S.
Food and Drug Administration (USFDA) closed an inspection at its
contract manufacturing facility in Washington with three
observations
    ** More than 271,000 shares traded by 02:30 p.m. IST, 0.8x
times their 30-day avg
    ** JUBA on track to snap three straight sessions of gains,
if current trends hold 
    ** Including session's move, stock is up 36.4% YTD 

 (Reporting by Navamya Ganesh Acharya in Bengaluru)
 ((Navamya.GaneshAcharya@thomsonreuters.com; +91 8805175330 ;))

Recent news on Jubilant Pharmova

See all news